Abilify and Exforge drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Exforge (amlodipine besylate; valsartan). Common drug interactions include cardiac failure among females and bruxism among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Exforge. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,455 Abilify users. Check the latest studies of Abilify.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.



On Aug, 05, 2026

45 people who take Abilify and Exforge together, and have interactions are studied.

Abilify and Exforge drug interactions.

What are the common drug interactions of Abilify and Exforge, by gender? *:

female:

  1. Cardiac failure
  2. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  3. Urinary tract infection
  4. Paresis (a condition of muscular weakness)
  5. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  6. Monoparesis (one limb is very weak, but not completely paralyzed)
  7. Diplegia (paralysis of corresponding parts on both sides of the body)
  8. Fall
  9. Confusional state
  10. Nephrolithiasis (calculi in the kidneys)

male:

  1. Bruxism (habitual grinding of the teeth, typically during sleep)
  2. Pruritus (severe itching of the skin)
  3. Asthenia (weakness)
  4. Chronic kidney disease
  5. Dehydration (dryness resulting from the removal of water)
  6. Emotional distress
  7. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  8. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
  9. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  10. Pain

What are the common drug interactions of Abilify and Exforge, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Drug ineffective
  2. Maternal exposure during pregnancy (use of substance during pregnancy)
  3. Premature delivery
  4. Premature rupture of membranes
  5. Threatened labour (premature labour is the onset of labour between 24 and 37 weeks of pregnancy)

40-49:

n/a

50-59:

  1. Bruxism (habitual grinding of the teeth, typically during sleep)
  2. Pruritus (severe itching of the skin)
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Arthralgia (joint pain)
  5. Dyskinesia (abnormality or impairment of voluntary movement)
  6. Eye irritation
  7. Weight increased
  8. Asthenia (weakness)
  9. Dehydration (dryness resulting from the removal of water)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

60+:

  1. Cardiac failure
  2. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  3. Anxiety
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Chronic kidney disease
  6. Confusional state
  7. Emotional distress
  8. Oxygen saturation decreased
  9. Pain
  10. Psychomotor skills impaired

What are the existing conditions these people have? *

  1. High Blood Pressure: 21 people, 46.67%
  2. Type 2 Diabetes: 15 people, 33.33%
  3. High Blood Cholesterol: 12 people, 26.67%
  4. Bipolar Disorder (mood disorder): 12 people, 26.67%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 15.56%
  6. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 11.11%
  7. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 11.11%
  8. Psychotic Disorder: 3 people, 6.67%
  9. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 6.67%
  10. Mania (a state of abnormally elevated or irritable mood): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Exforge?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Exforge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Exforge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exforge and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and amlodipine besylate; valsartan (the active ingredients of Abilify and Exforge, respectively), and Abilify and Exforge (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: